Creation of a Model Comparing 6-Minute Walk Test to Metabolic Equivalent in Evaluating Treatment Effects in Pulmonary Arterial Hypertension
- 1 July 2007
- journal article
- clinical trial
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 26 (7), 732-738
- https://doi.org/10.1016/j.healun.2007.04.013
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Six minute walk distance in healthy subjects aged 55–75 yearsRespiratory Medicine, 2006
- Six‐minute walk distance in healthy Singaporean adults cannot be predicted using reference equations derived from Caucasian populationsRespirology, 2006
- The Prognostic Value of a Nomogram for Exercise Capacity in WomenNew England Journal of Medicine, 2005
- The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: Demonstration of a ceiling effectVascular Pharmacology, 2005
- Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic reviewEuropean Heart Journal, 2005
- ATS StatementAmerican Journal of Respiratory and Critical Care Medicine, 2002
- The body weight–walking distance product as related to lung function, anaerobic threshold and peakV̇O2in COPD patientsRespiratory Medicine, 2001
- Reference Equations for the Six-Minute Walk in Healthy AdultsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in menJournal of the American College of Cardiology, 1993
- Treadmill exercise in assessment of the functional capacity of patients with cardiac diseaseThe American Journal of Cardiology, 1972